Urological cancer care pathways: Development and use in the context of systematic reviews and clinical practice guidelines

World Journal of Urology

Volumn 29, Issue 3, 2011, Pages 291-301

  MacLennan, Sara Jane ^a   MacLennan, Steven J ^a   Imamura, Mari ^a   Omar, Muhammad Imran ^a   Vale, Luke ^a   Lam, Thomas ^a   Royle, Pamela ^a   Royle, Justine ^a   Swami, Satchi ^b   Pickard, Rob ^c   McClinton, Sam ^c   Griffiths, T R Leyshon ^d   Dahm, Philipp ^e   N'Dow, James ^a,c,f  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b British Association of Urological Surgeons   (United Kingdom)

^c The British Association of Urological Surgeons (BAUS) Section of Academic Urology   (United Kingdom)

^d LEICESTER GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f Austria   (Netherlands)

Author keywords

Care pathways; Clinical practice guidelines; Systematic review; Urological cancer

Indexed keywords

DECISION MAKING; EVIDENCE BASED MEDICINE; HUMAN; LITERATURE; NOMENCLATURE; PRACTICE GUIDELINE; REVIEW; URINARY TRACT CANCER;

DECISION MAKING; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; REVIEW LITERATURE AS TOPIC; TERMINOLOGY AS TOPIC; UROLOGIC NEOPLASMS;

EID: 79957493996     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0660-9     Document Type: Review

References (21)

1. Evidence-Based Medicine Working Group (1992) Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 268: 2420-2425.
2. Mulrow CD (1994) Systematic reviews: rationale for systematic reviews. BMJ 309: 597.
3. Garg AX, Hackam D, Tonelli M (2008) Systematic review and meta-analysis: when one study is just not enough. Clin J Am Soc Nephrol 3: 253-260.
4. Tseng TY, Dahm P, Poolman RW, Preminger GM, Canales BJ, Montori VM (2008) How to use a systematic literature review and meta-analysis. J Urol 180: 1249-1256.
5. MacDonald SL, Canfield SE, Fesperman SF, Dahm P (2010) Assessment of the methodological quality of systematic reviews published in the urological literature from 1998 to 2008. J Urol 184: 648-653.
6. Schulz KF, Altman DG, Moher D, For the CONSORT Group (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340: c332.
7. Moher D, Liberati A, Tetzlaff J, Altman DG, Group ThePRISMA (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339: b2535. doi: 10. 1136/bmj. b2535.
8. Scales CD Jr, Norris RD, Keitz SA, Peterson BL, Preminger GM, Vieweg J, Dahm P (2007) A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature. J Urol 177: 1090-1094 (discussion 1094-1095).
9. EPPI Centre (2010) Setting scope and methods for the review. http://eppi. ioe. ac. uk/cms/Default. aspx?tabid=171.
10. Arksey H, O'Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8: 19-32.
11. Katz DL, Williams AL, Girard C, Goodman J, Comerford B, Behrman A, Bracken MB (2003) The evidence base for complementary and alternative medicine: methods of evidence mapping with application to CAM. Altern-Ther-Health-Med 9: 22-30.
12. The Global Evidence Mapping Initiative (2009) Traumatic brain and spinal cord injury. http://www. evidencemap. org.
13. Campbell H, Hotchkiss R, Bradshaw N, Porteous M (1998) Integrated Care Pathways. BMJ 316: 133-137.
14. Hammond R (2002) Integrated care pathways. Chartered Society of Physiotherapists. PA46: Feb 2002.
15. Jones T, de Luc K, Coyne H (1999) Managing care pathways: the quality and resources of hospital care. The Association of Certified Chartered Accountants, London.
16. European Pathway Association (2010) Clinical/care pathways [Online] Available: http://www. e-p-a. org/000000979b08f9803/index. html. Accessed 13/09/10.
17. Jones T (2000) Implementation of hospital care pathways for patients with schizophrenia. J Nurs Manag 8: 215-225.
18. Oxman AD, Schünemann HJ, Fretheim A (2006) Improving the use of research evidence in guideline development 2: priority setting. Health Res Policy Syst 4: 14. doi: 10. 1186/1478-4505-4-14.
19. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL (1987) Methods for the economic evaluation of health care programmes. Oxford University Press, Oxford.
20. Fox-Rusby J, Cairns J (eds) (2005) Economic evaluation. Open University Press, Maidenhead.
21. Tappenden P, Chilcott JB, Eggington S, Oakley J, McCabe C (2004) Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-β and glatiramer acetate for multiple sclerosis. Health Technol Assess 8: 1-92.